Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Case Study: How TGen Secures their Data with Identity-First Security John Forrister, Vice President Information Security, Translational Genomics Research Institute (TGen) The Translational Genomics Research Institute (TGen) is a pioneer in the biotechnology industry conducting groundbreaking genomic research that has be... 7 months ago | 25 mins Identify MOA and Companion Biomarkers in Oncology using Multi-Omic Analyses Stefano Cairo, PhD, Senior Global Scientific Director & Gilad Silberberg, PhD Head of Bioinformatics There is a significant need for better understanding of an oncology therapeutic’s mechanism of action while in preclinical studies, to then translate ... 3 months ago | 54 mins Best Practices in Translational Research Dr. Kalyanam Shivkumar, Dr. Dogulas P. Zipes Join our interactive webinar session with Kalyanam Shivkumar, MD, PhD, FACC, editor-in-chief of JACC: Clinical Electrophysiology to learn strategies o... 1 year ago | 61 mins High-Quality Peer Review of Clinical and Translational Research Dr. Fred Kusumoto & Dr. Viviany Taqueti Peer review is critical to the integrity and validity of scientific progress. A high-quality peer review of a manuscript provides value to the authors... 2 years ago | 61 mins Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck SCCs Francis Burrows, PhD, VP of Translational Research, Kura Oncology Tipifarnib is a potent and highly selective inhibitor of farnesyltransferase (FT). FT catalyzes the post-translational attachment of farnesyl grou... 3 years ago | 43 mins 固形がんにおけるDNAミスマッチ修復(MMR) 機能異常とその臨床的意義 〜IHC検査とがん免疫療法の臨床事例を踏まえて〜 Dr. Takeshi Kuwata and Dr. Akihito Kawazoe, both from National Cancer Center Hospital East, Chiba, Japan (Note: This webinar will be presented in Japanese.) In this webinar, our speakers will discuss mechanisms and clinical evaluation of DNA mismatch repa... 11 months ago | 62 mins Approaches & Challenges in Choosing the Right Translational Oncology Indication Zaki Sellam, Gary Brandam, Emmanuel Grillot, Alex Moreau In this innovative panel discussion, industry leaders will gather to share strategies and tactics on how to choose a translational oncology indication... 2 years ago | 88 mins High-Quality Peer Review of Clinical and Translational Research Dr. Fred Kusumoto & Dr. Viviany Taqueti Peer review is critical to the integrity and validity of scientific progress. A high-quality peer review of a manuscript provides value to the authors... 2 years ago | 61 mins High-Quality Peer Review of Clinical and Translational Research Dr. Fred Kusumoto & Dr. Viviany Taqueti Peer review is critical to the integrity and validity of scientific progress. A high-quality peer review of a manuscript provides value to the authors... 2 years ago | 61 mins The Omic Revolution: Leveraging Multiomic Integration... Michael Ritchie, PhD, MBA The era of leveraging genomics and transcriptomics has yielded a deeper understanding of the molecular underpinnings of neoplastic transformation and ... 12 months ago | 50 mins Load more